Brief: Rubius Therapeutics Reports First Quarter 2022 Financial Results

Rubius Therapeutics

10/05/2022 13:21

May 10 (Reuters) - Rubius Therapeutics Inc  RUBY.O :
    * RUBIUS THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * Q1 LOSS PER SHARE $0.58
    * AS OF MARCH 31, 2022, CASH, CASH EQUIVALENTS AND
INVESTMENTS
WERE $176.5 MILLION, COMPARED TO $225.8 MILLION AS OF DEC 31,
2021
    * AS OF MARCH 31, 2022, CASH, CASH EQUIVALENTS AND
INVESTMENTS
PROVIDES RUBIUS WITH A CASH RUNWAY INTO SECOND HALF OF 2023
    * Q1 EARNINGS PER SHARE VIEW $-0.58 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9yd18k 
Further company coverage:  RUBY.O 

 ((Reuters.Briefs@thomsonreuters.com;))